Application of data mining techniques in pharmacovigilance.
about
Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approachGathering and exploring scientific knowledge in pharmacovigilancePostmarket drug surveillance without trial costs: discovery of adverse drug reactions through large-scale analysis of web search queriesInformatics, evidence-based care, and research; implications for national policy: a report of an American Medical Informatics Association health policy conference.Rapid evaluation of human biomonitoring data using pattern recognition systems.Risk of hepatotoxicity associated with the use of telithromycin: a signal detection using data mining algorithms.Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database.Comparison and validation of data-mining indices for signal detection: using the Korean national health insurance claims database.Mining multi-item drug adverse effect associations in spontaneous reporting systemsExtraction of electronic health record data in a hospital setting: comparison of automatic and semi-automatic methods using anti-TNF therapy as model.Statistical Mining of Potential Drug Interaction Adverse Effects in FDA's Spontaneous Reporting System.Pharmacovigilance in oncology: evaluation of current practice and future perspectives.Starting a pharmacovigilance center: Actions for implementation.Identifying potential adverse effects using the web: a new approach to medical hypothesis generation.Automatic signal extraction, prioritizing and filtering approaches in detecting post-marketing cardiovascular events associated with targeted cancer drugs from the FDA Adverse Event Reporting System (FAERS)Biclustering of adverse drug events in the FDA's spontaneous reporting system.Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms.Trends of reporting of 'serious'vs. 'non-serious' adverse drug reactions over time: a study in the French PharmacoVigilance Database.Signal detection to identify serious adverse events (neuropsychiatric events) in travelers taking mefloquine for chemoprophylaxis of malariaApplication of pharmacovigilance methods in occupational health surveillance: comparison of seven disproportionality metrics.Signal detection methodologies to support effective safety management.Detection of pharmacovigilance-related adverse events using electronic health records and automated methods.Effect of consumer reporting on signal detection: using disproportionality analysis.Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System DatabaseDevelopment of a detection algorithm for statin-induced myopathy using electronic medical records.Identifying Adverse Drug Events by Relational Learning.Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome.High-Performance Signal Detection for Adverse Drug Events using MapReduce Paradigm.Collecting and sharing information about harms.Noscapine may increase the effect of warfarin.Methods for retrospective detection of drug safety signals and adverse events in electronic general practice records.AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting System.Can drugs induce or aggravate sleep apneas? A case-noncase study in VigiBase® , the WHO pharmacovigilance database.Who receives prescriptions for smoking cessation medications? An association rule mining analysis using a large primary care database.Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database.Traditional Chinese medicine pharmacovigilance in signal detection: decision tree-based data classification.Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial.Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database.Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors.
P2860
Q28481469-A6B01EAD-4465-4957-A8E0-7BDA93919605Q28536855-EC75FB0C-F8D4-4DCE-A7C7-7660E38F7512Q28677138-31E219FF-5566-4E5D-9ECC-B9C521C3922BQ30432968-06C2BD93-F03F-439B-B0DC-87B7B4B6CFA1Q31159951-247560D7-DB3D-4CDD-8890-43C26ED49E8BQ33387169-45468404-A604-46F6-8251-04782BCA0919Q33692818-5485DAF8-1535-445D-8D5B-2C519A4C3624Q34082600-AF7D10FF-6ADB-48D2-B6DE-F6E318FE38DCQ34259525-165D9C74-5C56-41CA-9625-EFD22F319371Q34572340-5C51B628-6373-4C27-B8DD-AA002C489A04Q34584149-212000D4-E093-4B4A-9807-E4E777594739Q35183601-BBB214AB-E876-4E6F-A913-A70745521A35Q35411535-A8572263-8424-4E31-8D18-9AA29E52147AQ35504449-BBB81032-AFE7-4113-80EA-0A7CEE4EE782Q35673776-504284BB-3D8D-4948-9FD7-3E9D56FBF833Q35764731-91193948-CD51-4ECC-82E9-F47BCFBA64B1Q35809210-C99BC47A-6A93-48A5-AC6C-2B9F1B2B0AAAQ36088026-E0973322-E8CE-4EC9-A6F1-47FADD8B4FC5Q36184868-2AA956FB-1D4E-46CF-9A78-8F8562B0F4DFQ36229893-8967FA0E-5692-4179-A857-DC4E734C659AQ36905865-F7F458CD-9C37-4200-B7D6-4027CB235D8EQ36936563-3C8EE1C1-B9D7-4225-A290-684AA4261BB9Q36984253-572354F7-2B8A-4F39-B503-7DBD89A26ABBQ37723303-C03DC348-D0BC-436D-A43E-1800C904A40DQ38093266-0729ECDD-4E17-4E6D-8CC5-A0891A264B12Q40879770-704449CF-E195-4A04-B6E4-3C95823DC720Q41226295-BD3DA275-5144-4846-9148-BA1441647639Q42037888-C373724F-2805-494B-95AF-98EF9F69D2ACQ43023261-2FA75205-ECAA-4EBA-9A94-6ADF01CD0971Q43110258-F93C304D-33CA-4C37-8465-24B65993BF88Q44301592-0E1EF462-E3F7-48E8-B67F-16F3333F4451Q46036399-AD9C6799-3A72-4E54-8835-07E6317BF09DQ47779429-839C0BDC-DCF4-4629-B599-5F045271E81BQ48756869-E4B20E62-ABC9-4E53-B269-99B84856042BQ50556141-CC15156B-1AC2-498E-B15C-A8597F5F717CQ52361345-88A4A8BA-BBB3-4A0A-B004-AC669506DEDBQ52664035-B8B47474-1386-438D-873E-ABF0AD0D3DFFQ54420490-1F375054-97AE-459E-91F6-6EF23780111EQ55362163-D547C48B-2F7E-47AE-B51C-AA38A3696814
P2860
Application of data mining techniques in pharmacovigilance.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Application of data mining techniques in pharmacovigilance.
@ast
Application of data mining techniques in pharmacovigilance.
@en
type
label
Application of data mining techniques in pharmacovigilance.
@ast
Application of data mining techniques in pharmacovigilance.
@en
prefLabel
Application of data mining techniques in pharmacovigilance.
@ast
Application of data mining techniques in pharmacovigilance.
@en
P2860
P1476
Application of data mining techniques in pharmacovigilance.
@en
P2093
Andrew M Wilson
Anne Holbrook
P2860
P304
P356
10.1046/J.1365-2125.2003.01968.X
P407
P577
2004-02-01T00:00:00Z